Literature DB >> 20088159

Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion.

Tatjana Radjenovic-Petkovic1, Tatjana Pejcic, Desa Nastasijević-Borovac, Milan Rancic, Danijela Radojkovic, Milan Radojkovic, Ivanka Djordjevic.   

Abstract

UNLABELLED: The diagnostic value of tumor markers in pleural fluid is still the subject of debate. The aim of this work was to evaluate diagnostic value of carcinoembryonic antigen (CEA) in pleural fluid for differentiating malignant from non malign pleural effusion, and their additive value to cytological examination.
DESIGN: Prospective, case control study.
SETTING: Tertiary University hospital, Clinic for Lung Disease, Knez Selo. PATIENTS: Eighty two patients with pleural effusion, forty one with malignant, and forty one with non malignant pleural effusion. MEASUREMENTS AND
RESULTS: Levels of CEA in pleural fluid was measured by IRMA CEA methods, INEP Belgrade. Patients with lung cancer were found to have significantly higher CEA levels than patients with non malign pleural effusion. Using cut off values of 2.4 ng/ml, the sensitivity of marker was 78%, and specificity 95.1% (CI 95%). The addition of CEA to cytology increase diagnostic rate from 68 to 85.3%.
CONCLUSION: CEA may represent a helpful adjunct to cytology in order to include malignancy as probable diagnosis, thus guiding the selection of patients for more invasive procedures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20088159

Source DB:  PubMed          Journal:  Med Arh        ISSN: 0350-199X


  4 in total

1.  [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].

Authors:  Ruicheng Li; Zhaowei Gao; Ke Dong; Huiping Wang; Huizhong Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

2.  Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.

Authors:  Klaus Hackner; Peter Errhalt; Sabin Handzhiev
Journal:  Ther Adv Med Oncol       Date:  2019-05-22       Impact factor: 8.168

3.  Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma from lung cancer using pleural carcinoembryonic antigen and hyaluronic acid levels.

Authors:  Takeshi Saraya; Kosuke Ohkuma; Masachika Fujiwara; Haruyuki Ishii
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

4.  Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor.

Authors:  Jian Wang; Zhe-Xiang Feng; Tao Ren; Wei-Yu Meng; Imran Khan; Xing-Xing Fan; Hu-Dan Pan; Liang Liu; Yi-Jun Tang; Xiao-Jun Yao; Run-Ze Li; Mei-Fang Wang; Elaine Lai-Han Leung
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.